Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Hemorrhage 12Neoplasms 7Leiomyoma 6Breast Neoplasms 6Thrombocytopenia 3Postoperative Hemorrhage 3Meningioma 3Hematologic Neoplasms 3Urinary Bladder Neoplasms 2Seroma 2Seizures 2Prostatic Neoplasms 2Myofibroma 2Menorrhagia 2Brain Neoplasms 2Bone Neoplasms 2Blood Loss, Surgical 2Wrist Fractures 1Urologic Diseases 1Urinary Tract Infections 1Urinary Retention 1Thromboembolism 1Stomach Neoplasms 1Staphylococcal Infections 1Spasm 1Sleep Initiation and Maintenance Disorders 1Skin Neoplasms 1Sepsis 1Schizophrenia, Treatment-Resistant 1Schizophrenia 1

Interventions

Tranexamic Acid 1Hemipelvectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pelvic Mass × Tranexamic Acid × Clear all
NCT03128866 2026-03-05

Tranexamic Acid in Reducing Blood Loss in Patients With Pelvic Tumors Undergoing Hemipelvectomy Surgery

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Active not recruiting
80 enrolled

Pelvic Mass

Data powered by HemOnc (CC BY 4.0) Colophon âš¡